Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation

Scleromyxedema, the most severe manifestation of the spectrum of lichen myxedematosus, is characterized by cutaneous mucinosis, extracutaneous manifestations, and a monoclonal gammopathy. Seven of 8 patients evaluated at our center were treated with high-dose melphalan (180 mg/m(2) intravenously) an...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Donato, Michele L., Feasel, Adrienne M., Weber, Donna M., Prieto, Victor G., Giralt, Sergio A., Champlin, Richard E., Duvic, Madeleine
Формат: Artigo
Язык:Inglês
Опубликовано: The American Society of Hematology 2006
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895605/
https://ncbi.nlm.nih.gov/pubmed/16179379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2004-12-4870
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы